Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...

Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Finding the right solution for weight loss can feel overwhelming, especially with so many options available. While ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.

StudyFinds' Dr. Faith Coleman looks at the common mistakes patients make using GLP-1 agonists like Ozempic and Wegovy.

Less than a fifth of large employers in the U.S. include coverage for the popular but pricey weight loss drugs Wegovy and ...

That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a ...

Less than one-fifth of large companies in the United States cover the popular, but pricey weight-loss drugs Wegovy and ...